The Antibody Drugs Effectiveness at Lower Doses


Two Eli Lilly & Co. antibody-based drugs reduced Covid-19-related hospitalizations and deaths among recently diagnosed patients when given at lower doses than previously tested, a new study found, which could help stretch supplies of the therapy. "These antibodies have a profound impact on the course of the disease," Lilly Chief Scientific Officer Daniel Skovronsky said in an interview. For the whole story check out the link right here.

0 comments

© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.